I agree that this site is using cookies. You can find further informations here.
X
Jesson, Gérald
7  results:
Search for persons X
?
1

Enhanced Bioavailability and Reduced Variability of Dasatin..:

Lennernäs, Hans ; Brisander, Magnus ; Liljebris, Charlotta..
Clinical Pharmacology in Drug Development.  , 2024
Link: https://doi.org/10.1002/..
 
?
2

Despite warnings, co‐medication with proton pump inhibitors..:

Larfors, Gunnar ; Andersson, Per ; Jesson, Gérald...
European Journal of Haematology.  111 (2023)  4 - p. 644-654 , 2023
Link: https://doi.org/10.1111/..
 
?
3

Carbon Dioxide-Mediated Generation of Hybrid Nanoparticles ..:

Jesson, Gérald ; Brisander, Magnus ; Andersson, Per...
Pharmaceutical Research.  31 (2013)  3 - p. 694-705 , 2013
Link: https://doi.org/10.1007/..
 
?
4

Parallel Nanoliter Microfluidic Analysis System:

Andersson, Per ; Jesson, Gerald ; Kylberg, Gunnar..
Analytical Chemistry.  79 (2007)  11 - p. 4022-4030 , 2007
Link: https://doi.org/10.1021/..
 
?
5

Integrated Microfluidic Compact Disc Device with Potential ..:

Andersson, Per ; Söderman, Tobias ; Thorsén, Gunnar...
Clinical Chemistry.  51 (2005)  10 - p. 1985-1987 , 2005
Link: https://doi.org/10.1373/..
 
?
6

Despite warnings, co-medication with proton pump inhibitors..:

Larfors, Gunnar ; Andersson, Per ; Jesson, Gérald...
European Journal of Haematology, 0902-4441, 2023.  , 2023
Link: http://urn.kb.se/resolve..
 
?
7

Carbon Dioxide-Mediated Generation of Hybrid Nanoparticles ..:

Jesson, Gérald ; Brisander, Magnus ; Andersson, Per...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931930.  , 2013
Link: http://www.ncbi.nlm.nih...
 
1-7